CBD Industry Toxicology Data Review

Three Points to Discuss Part 3 - The Curious Case of RP427

Three Points to Discuss Part 2 - Ethics and the FSA

Three Points to Discuss Part 1 - The FSA and the ASA

Escalation - a preview of The Hemp Hound Agency's meeting with the FSA to discuss the Public Interest Disclosure Complaint against their handling of novel foods for CBD products

The Hemp Hound Agency's review of Cannabis in the UK

Public Interest Disclosure complaint Update (21/07/23)

The Deloitte report: A Controversial Collaboration Shrouded in Industry Influence

Killing in the Name of .... - A look at the MHRA's yellow card list for Cannabis Sativa

The true extent of control

Leading the pack

Hemp & CBD Industry Poll: 20/02/2023

Deloitte - A look at those about to redefine Novel Food Regulations

February's Directory Push: US/UK edition

Communication issues

Ask the MHRA

Battleplans for 2023

The Hemp Hound Reset!

Have EIHA dropped the ball?

'Ask The FSA' FAQ's: Cold Press Hemp Oil with an Advertised Cannabinoid Content, and Article 4's